top of page
All Posts


🚨 The Real Reason Pharma Is Struggling To Keep The Market Pace: Too Many Voices. Not Enough Deciders.
We talk a lot in pharma about challenges — tough regulations, rising R&D costs, and long timelines. But let’s be honest: The biggest...

RegWise
Aug 282 min read


Big Pharma vs. Small Pharma/biotech
Here’s a more personalized comparison between Big Pharma and Small Pharma/biotech , pitched as if we’re sharing a coffee — your career...

RegWise
Jul 263 min read


💊 Medicine Prices: Why Higher Prices Might Actually Save More Lives (and Money)
When we hear about rising medicine prices, the instinctive reaction is concern, and for good reason. Millions of people struggle to...

RegWise
May 33 min read


The Art of Predicting Procedure Timelines with Accuracy in Regulatory Affairs
Accurate prediction of procedure timelines is one of the most significant challenges in regulatory affairs. A product approval process (a...
Bernardo Diaz
Apr 53 min read


The Regulatory Affairs Department: Key to Modern Business Success
In today's global business landscape of intense regulation and speed, the Regulatory Affairs (RA) department has become an essential...
Bernardo Diaz
Mar 224 min read


How Regulatory Affairs Can Communicate Effectively with Upper Management in Pharmaceutical Companies
How Regulatory Affairs Can Communicate Effectively with Upper Management in Pharmaceutical Companies In the pharmaceutical industry,...

RegWise
Mar 94 min read
bottom of page